bf/NASDAQ:NAUT_icon.jpeg

NASDAQ:NAUT

Nautilus Biotechnology, Inc.

  • Stock

USD

Last Close

2.88

26/07 20:00

Market Cap

284.35M

Beta: 0.81

Volume Today

55.14K

Avg: 103.59K

PE Ratio

−5.53

PFCF: −8.75

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
626.60M
-
-9.62K
100.00%
-15.62M
162,293.43%
-50.31M
222.14%
-57.92M
15.12%
-63.67M
9.93%
depreciation and amortization
548
-
2.35M
428,002.19%
2.84M
21.14%
3.42M
20.20%
5.71M
67.01%
deferred income tax
774.50K
-
-393K
-
stock based compensation
110
-
369K
335,354.55%
7.93M
2,050.14%
10.38M
30.83%
12.14M
16.93%
change in working capital
1.33M
-
-774.61K
158.36%
-1.39M
79.06%
-22K
98.41%
-788K
3,481.82%
-3.22M
308.50%
accounts receivables
inventory
accounts payables
107.25K
-
123K
14.69%
1.26M
925.20%
-561K
144.49%
393K
170.05%
other working capital
-881.85K
-
-1.51M
71.23%
-1.28M
15.03%
-227K
82.31%
-393K
73.13%
other non cash items
-866.23M
-
-592
100.00%
295K
49,931.08%
320K
8.47%
-890K
378.13%
-2.27M
154.61%
net cash provided by operating activities
-238.30M
-
-9.66K
100.00%
-14.00M
144,756.14%
-39.24M
180.37%
-45.81M
16.73%
-51.71M
12.89%
investments in property plant and equipment
-926
-
-921K
99,360.04%
-2.27M
146.36%
-2.32M
2.42%
-2.44M
5.08%
acquisitions net
24.36K
-
136.69K
461.19%
-163.18M
119,471.59%
-71.60M
56.12%
purchases of investments
-68.36M
-
-221.79M
224.46%
-186.59M
15.87%
-112.89M
39.50%
sales maturities of investments
44.00M
-
85.10M
93.40%
163.18M
91.75%
71.60M
56.12%
other investing activites
1.20M
-
4.98K
99.58%
-24.36K
589.51%
-136.69K
461.19%
163.18M
119,471.59%
71.60M
56.12%
net cash used for investing activites
1.20M
-
4.05K
99.66%
-25.28M
624,272.84%
-138.96M
449.72%
-25.74M
81.48%
-43.73M
69.91%
debt repayment
common stock issued
75.90M
-
-7.96M
110.49%
330K
104.14%
368K
11.52%
common stock repurchased
-1.20M
-
-874.33K
27.04%
232K
-
264K
13.79%
dividends paid
other financing activites
145.19B
-
36
100.00%
75.90K
210,730.56%
335.41M
441,814.91%
-264K
-
net cash used provided by financing activities
145.19B
-
36
100.00%
75.90M
210,830,455.56%
327.45M
331.42%
562K
99.83%
368K
34.52%
effect of forex changes on cash
-144.95B
-
6.17K
100.00%
net change in cash
1.20M
-
-1.20B
100,099.95%
36.62M
103.06%
149.24M
307.50%
-70.98M
147.56%
-95.08M
33.94%
cash at beginning of period
1.20B
-
595K
99.95%
37.22M
6,155.29%
186.46M
400.98%
115.48M
38.07%
cash at end of period
1.20M
-
595
99.95%
37.22M
6,255,194.12%
186.46M
400.98%
115.48M
38.07%
20.40M
82.34%
operating cash flow
-238.30M
-
-9.66K
100.00%
-14.00M
144,756.14%
-39.24M
180.37%
-45.81M
16.73%
-51.71M
12.89%
capital expenditure
-926
-
-921K
99,360.04%
-2.27M
146.36%
-2.32M
2.42%
-2.44M
5.08%
free cash flow
-238.30M
-
-10.59K
100.00%
-14.92M
140,785.91%
-41.51M
178.27%
-48.13M
15.95%
-54.15M
12.51%

All numbers in USD (except ratios and percentages)